Methods of ophthalmic administration
US6397849B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 2, 1999 |
| Grant date | Jun 4, 2002 |
| Priority date | — |
| Expiry date | Aug 2, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/908
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Intrascleral injection of a therapeutic or diagnostic material at a location overlying the retina provides a minimally invasive technique for delivering the agent to the posterior segment of the eye. The procedure also allows for close proximity of the material to the targeted site and can be effectively used to treat conditions associated with the posterior segment of the eye, including macular degeneration, vein occlusion, and diabetic retinopathy. The sclera can be used to hold a depot of the material such as for sustained released or as a conduit for propelling material through whereby the material is delivered immediately to the underlying tissues but without physically penetrating the sclera with an instrument or otherwise unreasonably traumatizing the eye.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.